233 related articles for article (PubMed ID: 9879603)
1. Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, southern Italy): results of a pilot vaccination project.
Da Villa G; Piccinino F; Scolastico C; Fusco M; Piccinino R; Sepe A
Res Virol; 1998; 149(5):263-70. PubMed ID: 9879603
[TBL] [Abstract][Full Text] [Related]
2. Successful mass vaccination against hepatitis B virus in a hyperendemic area in Italy.
Da Villa G
Res Virol; 1993; 144(4):255-8. PubMed ID: 8210705
[TBL] [Abstract][Full Text] [Related]
3. A pilot model of vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas.
Da Villa G; Piazza M; Iorio R; Picciotto L; Peluso P; De Luca G; Basile B
J Med Virol; 1992 Apr; 36(4):274-8. PubMed ID: 1578220
[TBL] [Abstract][Full Text] [Related]
4. Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B.
Cabezas C; Trujillo O; Balbuena J; Peceros FM; Terrazas M; Suárez M; Marin L; Apac J; Ramírez-Soto MC
PLoS One; 2020; 15(8):e0236993. PubMed ID: 32760100
[TBL] [Abstract][Full Text] [Related]
5. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.
Scognamiglio P; Girardi E; Fusco M; Piselli P; Spena SR; Maione C; Pisanti FA; Serraino D;
BMC Infect Dis; 2009 Jun; 9():86. PubMed ID: 19500412
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field.
Da Villa G; Picciottoc L; Elia S; Peluso F; Montanaro F; Maisto T
Vaccine; 1995 Sep; 13(13):1240-3. PubMed ID: 8578810
[TBL] [Abstract][Full Text] [Related]
7. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
Da Villa G; Romanò L; Sepe A; Iorio R; Paribello N; Zappa A; Zanetti AR
Vaccine; 2007 Apr; 25(16):3133-6. PubMed ID: 17280750
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.
Ni YH; Chang MH; Huang LM; Chen HL; Hsu HY; Chiu TY; Tsai KS; Chen DS
Ann Intern Med; 2001 Nov; 135(9):796-800. PubMed ID: 11694104
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
10. Minimization of hepatitis B infection by a 25-year universal vaccination program.
Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
[TBL] [Abstract][Full Text] [Related]
11. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program.
Tsen YJ; Chang MH; Hsu HY; Lee CY; Sung JL; Chen DS
J Med Virol; 1991 Jun; 34(2):96-9. PubMed ID: 1832440
[TBL] [Abstract][Full Text] [Related]
13. Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study.
Sagnelli E; Stroffolini T; Sagnelli C; Morisco F; Coppola N; Smedile A; Pisaturo M; Colloredo G; Babudieri S; Licata A; Brancaccio G; Andriulli A; Almasio PL; Gaeta GB;
J Med Virol; 2017 Dec; 89(12):2138-2143. PubMed ID: 28608566
[TBL] [Abstract][Full Text] [Related]
14. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy.
Bonanni P; Pesavento G; Bechini A; Tiscione E; Mannelli F; Benucci C; Nostro AL
Vaccine; 2003 Jan; 21(7-8):685-91. PubMed ID: 12531340
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk.
Bogomolski-Yahalom V; Granot E; Linder N; Adler R; Korman S; Manny N; Tur-Kaspa R; Shouval D
J Med Virol; 1991 Aug; 34(4):217-22. PubMed ID: 1834799
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
[TBL] [Abstract][Full Text] [Related]
17. A population-based study examining hepatitis B virus infection and immunization rates in Northwest China.
Ji Z; Wang T; Shao Z; Huang D; Wang A; Guo Z; Long Y; Zhang L; Su H; Zhang Q; Yan Y; Fan D
PLoS One; 2014; 9(5):e97474. PubMed ID: 24832483
[TBL] [Abstract][Full Text] [Related]
18. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
[No Abstract] [Full Text] [Related]
19. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
